In this video, Dr. Krzysztof Giannopoulos, Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland, explains the latest findings of the ATLAS trial presented at ASH 23.
active
In this video, Dr. Krzysztof Giannopoulos, Department of Experimental ...
In this video, Dr. Krzysztof Giannopoulos, Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland, explains the latest findings of the ATLAS trial presented at ASH 23.
active
In this video, Carmen Gonzalez, Cancer Center Clinica Universidad de ...
In this video, Carmen Gonzalez, Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Pamplona, Spain, explains the latest findings in Minimal Residual Disease (MRD) presented at ASH ...23.[+] Show More
active
In this video, Prof. Pieter Sonneveld, Head of the Department of ...
In this video, Prof. Pieter Sonneveld, Head of the Department of Haematology, Erasmus MC Cancer Institute explains the latest findings of the PERSEUS study presented at ASH 23.
active
In this video, Dr.Sæmundur Rögnvaldsson, Faculty of Medicine, ...
In this video, Dr.Sæmundur Rögnvaldsson, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, explains the latest findings of the iStopMM study presented at ASH 23.
active
In this video, Dr. Moshe Gatt, Department of Haematology, Hebrew ...
In this video, Dr. Moshe Gatt, Department of Haematology, Hebrew University of Jerusalem, Israel, explains the latest findings of the HBI0101 therapy for AL amyloidosis patients presented at ASH 23.
active
In this video, the chair of the ESMO Patient Advocates Working Group ...
In this video, the chair of the ESMO Patient Advocates Working Group (PAWG) and President of Europa Donna Slovenia, Tanja Spanic, explains how digitalisation helps personalise care throughout the patient ...journey.[+] Show More
active
Founder of Melanoma Patient Network Europe, Bettina Ryll explains in ...
Founder of Melanoma Patient Network Europe, Bettina Ryll explains in this video the importance of addressing the caregivers' needs at ESMO 2023 in Madrid, Spain.
active
MPE Board President Lise-Lott Eriksson explains patient engagement and ...
MPE Board President Lise-Lott Eriksson explains patient engagement and collaboration with national regulatory agencies at ESMO 2023 in Madrid, Spain.
active
Interview filmed with Dr Hermann Einsele, Director of the Department ...
Interview filmed with Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, to summarise the results of the clinical trial CARTITUDE-4, presented ...at European Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023. This trial evaluates the CAR-T treatment cilta-cel versus standard of care (PVD or DPD) in lenalidomide-refractory myeloma patients.[+] Show More
active
Prof. Monique Minnema, internist and haematologist at Academic Medical ...
Prof. Monique Minnema, internist and haematologist at Academic Medical Center, Amsterdam and the University Medical Center, Utrecht, The Netherlands, summarise in this interview the results of the clinical trial MonumenTAL-1, ...presented at EHA 2023. The phase I/II MonumenTAL-1 trial evaluates talquetamab in patients with relapsed/refractory myeloma.[+] Show More
active
Interview filmed with Dr María Victoria Mateos, Director of the ...
Interview filmed with Dr María Victoria Mateos, Director of the Myeloma Unit at the University Hospital of Salamanca-IBSAL in Spain, to summarise the results of the clinical trial Redirectt-1, presented ...at European Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023. This trial analyses the efficacy of teclistamab and talquetamab simultaneously in relapsed or refractory myeloma patients.[+] Show More
active
Interview filmed with Dr. Efstathios Kastritis, Associate Professor at ...
Interview filmed with Dr. Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Greece, to summarise the results of the clinical trial EMN 27, presented at European ...Hematology Association’s annual congress (EHA 2023 Virtual), held in June 2023.[+] Show More
